Certification is possible provided that
Acceptable DOACs are Dabigatran, Rivaroxaban and Apixaban.
Likely indications include:
Prior to certification, for pilots taking warfarin the INR should be demonstrated to be within the target range for 6 months (4 results at 2 monthly intervals) and 2 monthly laboratory testing should be continued on an ongoing basis. If the INR varies considerably within the target range on the initial readings, a longer period of surveillance may be required. Pilots taking DOACs should be free of side effects for a period of 3 months prior to fitness reassessment.
Class 1 applicants treated with warfarin are required to measure their INR on a ‘near patient’ testing system (such as CoaguChek S) 12 hours prior to flight and only fly if the INR is within the target range. The INR should be recorded in the Log Book. The Log Book should be reviewed at each medical certificate revalidation examination.
For LAPL pilots, a shorter period of stabilisation (6 weeks for DOACs and 4 months for warfarin) may be acceptable provided there are no side effects and there is reliable evidence of INR stability in pilots taking warfarin.
We now have a vacancy for an Airspace Specialist based in our London office. The role plays a vital part in the ove… https://t.co/TlWtwMHuHt
19 hours ago
Emirates must now pay flight delay compensation for missed connections following Supreme Court decision https://t.co/M1ispXbXRv
7 days ago
We have a vacancy for a brand new role in our Flight Operations Dept. to set up a National Pilot Peer Assistant Net… https://t.co/qQehlpjwTs
9 days ago
Read all @UK_CAA
CAA response to FT article (‘MPs warn of Brexit damage to UK aerospace’)
22 March, 2018
Civil Aviation Authority welcomes Supreme Court decision refusing Emirates permission to appeal
16 March, 2018
Pilot fined for flying into area restricted for air displays
9 March, 2018
Read all News
‘Share the Air’ gets off to a flying start
1 December, 2017
Access to air travel
11 August, 2017
International women in engineering day
22 June, 2017
Read All Blogs